JPS6466130A - High polymer carcinostatic enhancer - Google Patents

High polymer carcinostatic enhancer

Info

Publication number
JPS6466130A
JPS6466130A JP62223644A JP22364487A JPS6466130A JP S6466130 A JPS6466130 A JP S6466130A JP 62223644 A JP62223644 A JP 62223644A JP 22364487 A JP22364487 A JP 22364487A JP S6466130 A JPS6466130 A JP S6466130A
Authority
JP
Japan
Prior art keywords
enhancer
kinin
carcinostatic agent
usual dose
carcinostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62223644A
Other languages
English (en)
Other versions
JP2528477B2 (ja
Inventor
Hiroshi Maeda
Yasuhiro Matsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP62223644A priority Critical patent/JP2528477B2/ja
Publication of JPS6466130A publication Critical patent/JPS6466130A/ja
Application granted granted Critical
Publication of JP2528477B2 publication Critical patent/JP2528477B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP62223644A 1987-09-07 1987-09-07 高分子制癌剤の増強剤 Expired - Lifetime JP2528477B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62223644A JP2528477B2 (ja) 1987-09-07 1987-09-07 高分子制癌剤の増強剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62223644A JP2528477B2 (ja) 1987-09-07 1987-09-07 高分子制癌剤の増強剤

Publications (2)

Publication Number Publication Date
JPS6466130A true JPS6466130A (en) 1989-03-13
JP2528477B2 JP2528477B2 (ja) 1996-08-28

Family

ID=16801415

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62223644A Expired - Lifetime JP2528477B2 (ja) 1987-09-07 1987-09-07 高分子制癌剤の増強剤

Country Status (1)

Country Link
JP (1) JP2528477B2 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282384A (en) * 1993-08-18 1995-04-05 European Community Drug delivery agents incorporating mitomycin
CN114917345A (zh) * 2021-04-07 2022-08-19 北京蛋白质组研究中心 靶向soat1蛋白的化合物在制备预防和/或治疗肝癌药物中的应用

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282384A (en) * 1993-08-18 1995-04-05 European Community Drug delivery agents incorporating mitomycin
GB2282384B (en) * 1993-08-18 1997-09-03 European Community Drug delivery agents incorporating mitomycin
CN114917345A (zh) * 2021-04-07 2022-08-19 北京蛋白质组研究中心 靶向soat1蛋白的化合物在制备预防和/或治疗肝癌药物中的应用
WO2022213878A1 (zh) * 2021-04-07 2022-10-13 北京蛋白质组研究中心 靶向SOAT1蛋白的化合物Ramipril在制备预防和/或治疗肝癌药物中的应用

Also Published As

Publication number Publication date
JP2528477B2 (ja) 1996-08-28

Similar Documents

Publication Publication Date Title
ATE192921T1 (de) Therapeutischer wirkstoff zur behandlung von melanomen
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
DE69635671D1 (de) Verwendung von roxithromycin zur herstellung eines medikaments zur verbesserung der biologischen und antiviralen aktivität von protease-inhibitoren
CA2326761A1 (en) Antitumor agent
MX9803563A (es) Preparacion terapeutica para la administracion transdermica de principios activos.
DK261490D0 (da) New pharmaceutical compound
IE871210L (en) Tissue plasminogen activator
KR880007089A (ko) 약리학용/화장용 약제(Pharmacological/Cosmetic Preparation)
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
ATE305791T1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
IL115189A (en) Transdermal therapeutic system containing scopolamine
UA27102C2 (uk) Склад для стабілізації плазми крові у процесі пастеризації, спосіб пастеризації плазми крові і засіб для терапії препаратом плазми
JPS6466130A (en) High polymer carcinostatic enhancer
HUP9603489A2 (hu) Gyógyszerkészítmény és eljárás előállítására
PL320342A1 (en) Thrombin inhibitor containing infusion solution, stable during storage
AU4620685A (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
JPS57112331A (en) Medical composition of ganoderma lucidum component
EP0340933A3 (en) Heparin-containing formulations
JPS57128635A (en) Pharmaceutical preparation of gamma-globulin for venoclysis
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
CA2405265A1 (en) Method of preventing or treating diabetes
WO1999013894A3 (en) Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
RU97112901A (ru) Тромболитические средства